Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Abstract Text:

K Mori,H Yoshioka,Y Itai,Y Okamoto,H Mori,N Takahashi,Y Saida,

OBJECTIVE: The study objective was to distinguish between the features of tumorous and nontumorous arterioportal shunts on superparamagnetic iron oxide-enhanced MR imaging in patients with cirrhosis. SUBJECTS AND METHODS: Ten arterioportal shunts in eight patients, including four tumorous and six nontumorous arterioportal shunts, were evaluated on T2-weighted turbo spin-echo and T2(*)-weighted gradient-echo sequences before and after administration of superparamagnetic iron oxide. Qualitatively, the relative signal intensity of the arterioportal shunt compared with that of the surrounding liver parenchyma was categorized into three grades: high, slightly high, and not detected. Quantitatively, signal-to-noise ratio, contrast-to-noise ratio, lesion-to-liver contrast, and percentage enhancement were calculated and compared between tumorous and nontumorous arterioportal shunts by a nonparametric statistical test (Mann-Whitney test). RESULTS: Qualitatively, all four tumorous arterioportal shunts appeared as areas of slightly high or high intensity without and with superparamagnetic iron oxide on T2-weighted turbo spin-echo images and changed from isointensity to high intensity after the administration of superparamagnetic iron oxide on T2(*)-weighted gradient-echo images. All nontumorous arterioportal shunts except one could not be recognized without or with superparamagnetic iron oxide on either sequence. Quantitatively, with superparamagnetic iron oxide the contrast-to-noise ratio and the lesion-to-liver contrast of the tumorous arterioportal shunts were significantly higher than those of the nontumorous arterioportal shunts. CONCLUSION: Tumorous arterioportal shunts are seen as areas of reduced signal loss, whereas most nontumorous arterioportal shunts are seen as areas of normal signal loss, like the normal liver parenchyma. The difference is more marked on T2(*)-weighted gradient-echo images than on T2-weighted turbo spin-echo images.

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Publishing Authors By Initials

K Mori,H Yoshioka,Y Itai,Y Okamoto,H Mori,N Takahashi,Y Saida,

For similar complex mixtures: colloids: suspensions research abstracts see: complex mixtures: colloids: suspensions research

PUBMED ID PMID:

MEDLINE DATE:

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: AJR. American journal of roentgenology

VOLUME: 175

Page Numbers: 1659-64

Journal Abbreviation:

ISSN: 0361-803X

DAY: 15

MONTH: Dec

YEAR: 2000

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7708173

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Keywords Mesh Terms:

KEYWORDS: Suspensions

MESH TERMS: diagnostic use

Chemical & Substance for Abstract: Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. Information

Substance Name: Iron

Registry Number: 7439-89-6

Grant and Affiliation Information for Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.

AFFILIATION: Department of Radiology, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576 Japan.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: AJR Am J Roentgenol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide Related Publications

• Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
• Ductectatic mucinous cystic neoplasms of the pancreas: evaluation with MR cholangiopancreatography.
• Endoscopic submucosal dissection is useful and safe for intramucosal gastric neoplasms in the elderly.
• Immobilized biomolecules and electronic sensing devices.
• Immunolocalization of endothelin-B receptor in mouse intestinal tract.
• Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.
• Multiple hypersonographic spots in basal cell carcinoma.
• Overview on the expression of toxic gene products in Escherichia coli.
• Preprocedural MR imaging for percutaneous vertebroplasty: special interest in contrast enhancement.
• Primary structure of dog preproendothelin-3 and elevated gene expression in kidney affected with interstitial nephritis.
• Real-time polymerase chain reaction quantification of gene expression levels of murine endothelin-A and endothelin-B receptors: gene expression profiles by the standard curve method.
• Regulation of endothelin-1 expression and function by nutrient stress in mouse colon epithelia.
• Structure of the precursor of Xenopus laevis endothelin-3 and phylogenetic analysis.
• Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late, and whole triple arterial phase imaging.
• [Overview of MS: proposal of new MS definition/classification and review of the results of recent clinical trials]
• cDNA cloning and sequence analysis of Xenopus laevis preproendothelin-1.
• cDNA cloning, sequence analysis and organ distribution of horse preproendothelin-2.